Lataa...
Recombinant human activated protein C resets thrombin generation in patients with severe sepsis – a case control study
INTRODUCTION: Recombinant human activated protein C (rhAPC) is the first drug for which a reduction of mortality in severe sepsis has been demonstrated. However, the mechanism by which this reduction in mortality is achieved is still not clearly defined. The aim of the present study was to evaluate...
Tallennettuna:
| Päätekijät: | , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2005
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1297612/ https://ncbi.nlm.nih.gov/pubmed/16277710 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc3774 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|